Seth Lederman
2017
In 2017, Seth Lederman earned a total compensation of $575.8K as Chief Executive Officer at Tonix Pharmaceuticals Holding, a 25% decrease compared to previous year.
Compensation breakdown
| Option Awards | $103,344 |
|---|---|
| Salary | $472,500 |
| Total | $575,844 |
Lederman received $472.5K in salary, accounting for 82% of the total pay in 2017.
Lederman also received $103.3K in option awards.
Rankings
In 2017, Seth Lederman's compensation ranked 11,347th out of 14,666 executives tracked by ExecPay. In other words, Lederman earned more than 22.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,347 out of 14,666 | 23rd |
Division Manufacturing | 4,445 out of 5,768 | 23rd |
Major group Chemicals And Allied Products | 1,616 out of 2,074 | 22nd |
Industry group Drugs | 1,333 out of 1,730 | 23rd |
Industry Pharmaceutical Preparations | 1,041 out of 1,329 | 22nd |
Source: SEC filing on April 19, 2018.
Lederman's colleagues
We found three more compensation records of executives who worked with Seth Lederman at Tonix Pharmaceuticals Holding in 2017.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019